Overexpression of p34cdc2 protein kinase in epithelial ovarian carcinoma

Brigitte A. Barrette, Preeti J. Srivatsa, William A. Cliby, Gary L. Keeney, Vera J. Suman, Karl C. Podratz, Patrick C. Roche

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Objective: To investigate the role of expression of p34cdc2 protein kinase in normal, benign, and malignant ovarian epithelium. Material and Methods: Tissue sections from 24 patients with epithelial ovarian carcinoma (EOC) along with 6 normal ovarian specimens and 12 benign cystadenomas were incubated with mouse IgG monoclonal antibody to human p34cdc2 protein kinase, followed by detection with use of a standard peroxidaselabeled streptavidin-biotin technique. Immunohistochemical staining was graded and compared. Clinical data were also reviewed. Results: Normal surface epithelium and 10 of 12 benign cystadenomas failed to stain for p34cdc2 protein kinase. Of the 24 EOC specimens, however, 19 (79%) stained positively. The staining pattern or intensity was not associated with the histologie grade or surgical stage. Conclusion: Expression of p34cdc2 protein kinase is strongly up-regulated in most cases of EOC but not in normal epithelial ovarian tissue or in most cases of benign epithelial tumors evaluated. Therefore, it may be associated with early events in carcinogenesis. Redundant overexpression of cyclin-dependent kinases such as p34cdc2 may contribute to deranged cell cycle progression and proliferation of EOC. Observation of overexpression of p34cdc2 protein kinase in other malignant lesions suggests a common mechanism.

Original languageEnglish (US)
Pages (from-to)925-929
Number of pages5
JournalMayo Clinic proceedings
Issue number10
StatePublished - 1997

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Overexpression of p34cdc2 protein kinase in epithelial ovarian carcinoma'. Together they form a unique fingerprint.

Cite this